Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the long term safety, tolerability, and immunogenicity of ACC-001, an investigational active immunization product+, in subjects with mild to moderate Alzheimer's...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
Collaborators
NCT07571161 · Alzheimer Disease
NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
NCT06937229 · Alzheimer Disease, Agitation
NCT04579120 · Alzheimer Disease
NCT07633470 · Alzheimer Disease
CMRR Bordeaux CHU Pellegrin
Bordeaux
Hopital Roger Salengro
Lille
Hôpital Roger Salengro
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions